Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
Y Xu, P Li, Y Liu, D Xin, W Lei, A Liang… - Cancer …, 2022 - Wiley Online Library
Over the last two decades, several epi‐drugs, immune checkpoint inhibitors (ICIs) and
adoptive cell therapies have received clinical approval for use in certain types of cancer …
adoptive cell therapies have received clinical approval for use in certain types of cancer …
Management of angioimmunoblastic T-cell lymphoma (Aitl) and other T follicular helper cell lymphomas (Tfh ptcl)
H Ma, OA O'Connor, E Marchi - Seminars in Hematology, 2021 - Elsevier
Despite the remarkable improvements in the treatment and outcome of patients with
aggressive B-cell lymphoma, the peripheral T-cell lymphomas (PTCL) continue to carry a …
aggressive B-cell lymphoma, the peripheral T-cell lymphomas (PTCL) continue to carry a …